BioXcel Therapeutics (BX20.F) Q4 2025 Earnings

Nov 12Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-5.6
-4.12
-2.64
-1.16

Details

Expected EPS
-1.1558840000000001
Actual EPS
-1.8804680000000003
Surprise EPS
-0.72
Surprise Percent
-62.69%

Description

⁨BioXcel Therapeutics⁩ (⁦BX20.F⁩) has reported earnings of ⁦-1.8804680000000003⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts